T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
First Horizon
FHN
$12.4B
| $4.66M | ﹤0.01% |
275,411
+3,371
| +1% | +$53.3K |
|
|
ALEX
1477
DELISTED
Alexander & Baldwin
ALEX
| $4.62M | ﹤0.01% |
275,276
-482,433
| -64% | -$8.26M |
|
1478
MACOM Technology Solutions
MTSI
$23.9B
| $4.62M | ﹤0.01% |
79,545
+57,845
| +267% | +$3.59M |
|
|
CDK
1479
DELISTED
CDK Global, Inc.
CDK
| $4.61M | ﹤0.01% |
85,318
-7,408
| -8% | -$384K |
|
1480
MasTec
MTZ
$23.8B
| $4.58M | ﹤0.01% |
48,827
-5,898
| -11% | -$505K |
|
1481
STAAR Surgical
STAA
$1.29B
| $4.55M | ﹤0.01% |
43,210
-26,898
| -38% | -$2.69M |
|
|
AJRD
1482
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $4.54M | ﹤0.01% |
96,778
-2,137,654
| -96% | -$109M |
|
|
SFE
1483
DELISTED
Safeguard Scientifics, Inc.
SFE
| $4.49M | ﹤0.01% |
657,658
-250,937
| -28% | -$1.82M |
|
1484
KB Home
KBH
$3.44B
| $4.43M | ﹤0.01% |
95,244
+24,151
| +34% | +$998K |
|
1485
Pricesmart
PSMT
$5.49B
| $4.42M | ﹤0.01% |
45,739
-4,963
| -10% | -$482K |
|
1486
News Corp Class B
NWS
$17.9B
| $4.42M | ﹤0.01% |
188,577
-7,917
| -4% | -$171K |
|
|
SKX
1487
DELISTED
Skechers
SKX
| $4.39M | ﹤0.01% |
105,241
-7,167
| -6% | -$271K |
|
1488
Sprouts Farmers Market
SFM
$7.72B
| $4.38M | ﹤0.01% |
164,635
-3,904,705
| -96% | -$88.8M |
|
1489
American Financial Group
AFG
$12.1B
| $4.37M | ﹤0.01% |
38,317
+415
| +1% | +$42.9K |
|
|
UHT
1490
Universal Health Realty Income Trust
UHT
$571M
| $4.33M | ﹤0.01% |
63,895
-786
| -1% | -$51.7K |
|
|
ECOL
1491
DELISTED
US Ecology, Inc.
ECOL
| $4.33M | ﹤0.01% |
104,015
-115,681
| -53% | -$4.5M |
|
|
GNMK
1492
DELISTED
GenMark Diagnostics, Inc
GNMK
| $4.33M | ﹤0.01% |
181,226
-1,690,847
| -90% | -$31.4M |
|
1493
ITT
ITT
$19.5B
| $4.33M | ﹤0.01% |
47,635
+479
| +1% | +$39.5K |
|
1494
JetBlue
JBLU
$2.11B
| $4.33M | ﹤0.01% |
212,883
+14,790
| +7% | +$256K |
|
|
XEC
1495
DELISTED
CIMAREX ENERGY CO
XEC
| $4.28M | ﹤0.01% |
72,077
-19,340
| -21% | -$1.03M |
|
1496
Aecom
ACM
$8.09B
| $4.26M | ﹤0.01% |
66,480
-6,392
| -9% | -$364K |
|
|
SUMO
1497
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $4.25M | ﹤0.01% |
+225,371
| New | +$6.58M |
|
|
RAVN
1498
DELISTED
Raven Industries Inc
RAVN
| $4.23M | ﹤0.01% |
110,436
+43
| +0% | +$1.61K |
|
1499
Polaris
PII
$3.93B
| $4.2M | ﹤0.01% |
31,490
+1,938
| +7% | +$236K |
|
1500
Immunic
IMUX
$223M
| $4.18M | ﹤0.01% |
26,238
-15,210
| -37% | -$2.58M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.